These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3450885)

  • 1. [Back-ground factors which affect the outcome of steroid withdrawal therapy in patients with chronic type B hepatitis--statistical evaluation of the importance of the mode of HBV transmission].
    Tokita H; Shimizu M; Takahashi Y; Tanaka H; Yasuda M; Kojima M; Adachi N; Yoshida H
    Nihon Shokakibyo Gakkai Zasshi; 1987 Dec; 84(12):2706-13. PubMed ID: 3450885
    [No Abstract]   [Full Text] [Related]  

  • 2. Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
    Itoh S; Matsuo S; Oda T; Marutani K; Sasaki K
    Dig Dis Sci; 1990 Sep; 35(9):1110-4. PubMed ID: 2390925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
    Kumada H; Ikeda K; Yoshida A; Seto S; Tsukada T; Kojima M; Suzuki H; Mayumi M
    Jpn J Med; 1987 May; 26(2):217-22. PubMed ID: 3626161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
    Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A
    Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.
    Sagnelli E; Piccinino F; Manzillo G; Felaco FM; Filippini P; Maio G; Pasquale G; Izzo CM
    Hepatology; 1983; 3(5):690-5. PubMed ID: 6618436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
    Yokosuka O; Omata M; Imazeki F; Hirota K; Mori J; Uchiumi K; Ito Y; Okuda K
    Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Lee SD; Tong MJ; Wu JC; Lin HC; Tsai YT; Lo KJ
    J Hepatol; 1991 Mar; 12(2):246-50. PubMed ID: 2051004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
    Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
    Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
    Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T
    Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
    Brook MG; Main J; Yap I; Chan G; Karayiannis P; Crossey M; Thomas HC
    Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoprinosine in the treatment of chronic active hepatitis type B.
    Cianciara J; Laskus T; Gabinska E; Loch T
    Scand J Infect Dis; 1990; 22(6):645-8. PubMed ID: 1704640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
    Simon K; Gładysz A; Zalewska M; Machaj A
    Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K; Abb J; Farack UM; Wiebecke B
    Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B inactive carriers: clinical course and outcomes.
    Tong MJ; Trieu J
    J Dig Dis; 2013 Jun; 14(6):311-7. PubMed ID: 23433008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
    Hoofnagle JH; Davis GL; Pappas SC; Hanson RG; Peters M; Avigan MI; Waggoner JG; Jones EA; Seeff LB
    Ann Intern Med; 1986 Jan; 104(1):12-7. PubMed ID: 3940480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen.
    Shiraki K; Yoshihara N; Sakurai M; Eto T; Kawana T
    J Pediatr; 1980 Nov; 97(5):768-70. PubMed ID: 7431166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.